Larvol Delta - AVALON-Trial-Phase-2b-Study-of-MaveropepimutS-and-LowDose-Cyclophosphamide-in-Subjects-with-PlatinumResistant-Epithelial-Ovarian-Cancer

maveropepimut-S (MVP-S) - IMV Inc

cyclophosphamide - Generic mfg.

https://cslide.ctimeetingtech.com/gynae23hybrid/attendee/confcal/show/session/12

Oliver Dorigo

Dec 23, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next